Related Experiment Video
Updated: Jun 9, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
MUC5B rs35705950 Promoter Variant Is Associated with Usual Interstitial Pneumonia in Patients with Antisynthetase
Daphne Rivero-Gallegos1,2, Mayra Mejía1, Karol J Nava-Quiroz3
1Interstitial Lung Disease and Rheumatology Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico.
Abstract:
Background: The presence of the rs35705950 variant in the MUC5B gene promoter is a critical genetic risk factor in idiopathic pulmonary fibrosis (IPF). It has been associated with usual interstitial pneumonia (UIP) in several interstitial lung diseases (ILDs). In antisynthetase syndrome (ASSD), most high-resolution computed tomography (HRCT) patterns are inflammatory, but up to 13% have UIP, leading to a worse prognosis. Methods: This single-center study included 60 patients with ASSD-ILD. We investigated whether carrying the MUC5B rs35705950 promoter variant was associated with UIP. To estimate the strength of the association between the genotype of the MUC5B rs35705950 promoter variant and the fibrotic pattern we used the odds ratio (cOR), and to assess the effect of confounding variables (age, evolution time, and sex), we performed a logistic regression to obtained the adjusted odds ratio (aOR). Results: The GT genotype of the MUC5B rs35705950 promoter variant is associated with up to a 4-fold increased risk of UIP (cOR 5.0, 95% CI 1.13-22.10), and the effect was even maintained after adjusting for potentially confounding variables such as sex, age, and time to progression (aOR 5.2, 95% CI 1.04-25.89). Conclusions: our study supports the role of MUC5B rs35705950 in ASSD-ILD with UIP. It reinforces that this polymorphism in our population could have a similar genetic basis to that already described in other ILDs that present predominantly fibrotic patterns.
Insights
The MUC5B rs35705950 genetic variant increases the risk of usual interstitial pneumonia (UIP) in antisynthetase syndrome-interstitial lung disease (ASSD-ILD). This finding supports a shared genetic basis for fibrotic patterns in various interstitial lung diseases.
Area of Science:
- Pulmonology
- Genetics
- Rheumatology
Background:
- The MUC5B rs35705950 promoter variant is a key genetic risk factor for idiopathic pulmonary fibrosis (IPF).
- This variant is linked to usual interstitial pneumonia (UIP) patterns in various interstitial lung diseases (ILDs).
- Antisynthetase syndrome-ILD (ASSD-ILD) patients can present with UIP, indicating a poorer prognosis.
Purpose of the Study:
- To investigate the association between the MUC5B rs35705950 promoter variant and UIP in patients with ASSD-ILD.
- To determine if this genetic variant contributes to the development of fibrotic lung disease in ASSD.
Main Methods:
- A single-center study involving 60 patients diagnosed with ASSD-ILD.
- Genotyping for the MUC5B rs35705950 promoter variant.
- Logistic regression analysis was used to calculate crude (cOR) and adjusted odds ratios (aOR) for UIP, controlling for age, sex, and time to progression.
Main Results:
- The GT genotype of the MUC5B rs35705950 variant was associated with a significantly increased risk of UIP (cOR 5.0).
- This association remained significant after adjusting for confounding factors (aOR 5.2).
- The variant confers up to a 4-fold increased risk of developing UIP in ASSD-ILD patients.
Conclusions:
- The MUC5B rs35705950 variant plays a role in the development of UIP within the ASSD-ILD population.
- This finding suggests a common genetic etiology for fibrotic ILDs, including ASSD-ILD with UIP patterns.
- The study reinforces the importance of genetic factors in the pathogenesis of fibrotic lung diseases.
Related Concept Videos
Single Nucleotide Polymorphisms-SNPs
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Non-LTR Retrotransposons

